thyroid neoplasms/illamående

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 83 resultat

[Efficacy of preventing postoperative nausea and vomiting after thyroid tumor surgery by TAES at neiguan (P1): a clinical observation].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE To observe the clinical efficacy of transcutaneous acupoint electrical stimulation (TAES) combined intravenous injection and/or Neiguan (P6) injection with droperidol in preventing and treating post-operative nausea and vomiting (PONV) after thyroid tumor surgery. METHODS Recruited were

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Lenvatinib is a small oral molecule able to inhibit three of the extracellular and intracellular molecules involved in the modulation of angiogenesis and lymphangiogenesis: vascular endothelial growth factor receptor 1-3, fibroblast growth factor receptor 1-4, and platelet-derived growth factor

Lenvatinib: a new option for the treatment of advanced iodine refractory differentiated thyroid cancer?

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Lenvatinib mesylate (E7080; 4-[3-chloro-4-(N'-cyclopropylureido) phenoxy] 7-methoxyquinoline-6-carboxamide mesylate) is an oral molecule that inhibits multiple tyrosine kinase receptors such as VEGF-R-1-3, FGF-R-1-4, RET, c-KIT and PDGF-R-β. Phase I studies identified the maximum tolerated dose to

Effects of pretreatment with intravenous palonosetron for propofol-remifentanil-based anesthesia in breast and thyroid cancer surgery: a double-blind, randomized, controlled study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND We postulated that palonosetron, a novel antiemetic agent, might have the effect of alleviating injection pain from propofol and rocuronium. A double-blind, controlled study was undertaken to evaluate the effect of palonosetron on injection pain during total intravenous anesthesia and

Severe hyponatremia: a comorbidity with I131 therapy in a patient with papillary thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Hyponatremia is the most common electrolyte disorder in hospitalized patients, especially in elderly patients, in which morbidity varies widely in severity. A 64-year-old Thai woman with papillary thyroid cancer who developed hypothyroid state after thyroid hormone withdrawal for preparation of

Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Recombinant TSH is effective in providing exogenous TSH stimulation for patients with differentiated thyroid cancer on thyroid hormone-suppressive therapy. It allows for detection of thyroid remnant and metastases by radioiodine scan and by serum thyroglobulin determination. The sensitivity and

Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

During the administration of recombinant human TSH (rhTSH) to monitor differentiated thyroid carcinoma, mild side effects, such as nausea and headaches, often occur. The origin of these is not clear. Since changes in TSH and thyroid hormones can modulate some endothelial-derived factors, we aimed at

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Medullary thyroid cancers (MTCs) are neuroendocrine tumors, which secrete calcitonin and carcinoembryonic antigen, both of which can serve as tumor markers. Extensive and accurate surgical resection is the primary treatment for MTC, whereas the use of external beam radiotherapy is limited. Moreover,

Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Agents such as aflibercept, which target the angiogenic pathway, are of great interest as candidates for the management of metastatic differentiated thyroid cancer. Here, we report a patient who developed a hemorrhagic abdominal pseudoaneurysm shortly after being started on this

The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Many clinicians care for patients who have been treated for differentiated thyroid cancer. Recombinant thyrotropin, which stimulates iodine uptake in thyroid tissue, is a safe and effective diagnostic agent for those patients who require radioiodine scanning for routine follow-up. The combination of

Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE This study tested the hypothesis that administration of human recombinant thyroid-stimulating hormone (rhTSH: Thyrogen, thyrotropin alpha) could promote iodine-131 ((131)I) uptake in the therapy for metastatic or locally invasive differentiated thyroid cancer (DTC), obviating L-thyroxine

Recurrent thyroid storm induced by heretofore unrecognised causes in a patient with thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

An unusual encounter of a thyroid storm, on two separate occasions, is reported in a patient with metastatic differentiated thyroid cancer following initially direct trauma to, and later tumour embolisation of, a metastatic skeletal lesion. Shortly after a fall, our patient presented with pain and

Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Radioiodine-131 (I131) therapy for differentiated thyroid cancer (DTC) is generally a safe and effective treatment, but it has some potential side effects, which have been well described in adults but less analyzed in children. Our aim was to describe early and late adverse events of

High versus low radioiodine activity in patients with differentiated thyroid cancer: a meta-analysis.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND The purpose of the meta-analysis was to estimate the effectiveness and toxicity of low activity radioiodine ablation versus high activity in patients with differentiated thyroid cancer (DTC). METHODS A systematic review and meta-analysis was performed by including all randomized trials of

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE The aim of this study was to compare the efficacy and adverse effects of radioiodine (131I) therapy between two groups of patients with low-risk differentiated thyroid cancer (DTC) who received 30 mCi or 100 mCi radioiodine for ablation of the thyroid remnant after total

Tidigare
1
2
3
4
5
6
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning